356 results on '"Woo, Hyun Goo"'
Search Results
2. Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson’s disease
3. Cancer signature ensemble integrating cfDNA methylation, copy number, and fragmentation facilitates multi-cancer early detection
4. Artificial intelligence-driven drug repositioning uncovers efavirenz as a modulator of α-synuclein propagation: Implications in Parkinson’s disease
5. Single-cell transcriptome profiling of the stepwise progression of head and neck cancer
6. Critical roles of parkin and PINK1 in coxsackievirus B3-induced viral myocarditis
7. Comparing research trends with patenting activities in the biomedical sector: The case of dementia
8. Safe Utilization and Sharing of Genomic Data: Amendment to the Health and Medical Data Utilization Guidelines of South Korea
9. A comprehensive report on the FAOPS 2023 teaching workshop and education symposium
10. Immune checkpoint inhibitor monotherapy is sufficient to promote microenvironmental normalization via the type I interferon pathway in PD‐L1‐expressing head and neck cancer.
11. Integrative transcriptomic and genomic analyses unveil the IFI16 variants and expression as MASLD progression markers
12. YAP inactivation in estrogen receptor alpha-positive hepatocellular carcinoma with less aggressive behavior
13. Mitoribosome Defect in Hepatocellular Carcinoma Promotes an Aggressive Phenotype with Suppressed Immune Reaction
14. Mutations in the SARS-CoV-2 spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization
15. Loss of coactosin-like F-actin binding protein 1 (Cotl1) decreases platelet-mediated osteoclastogenesis and causes osteopetrosis phenotypes in mouse
16. Integration of National Health Insurance Claim Data and Animal Models Reveals Fexofenadine as a Promising Repurposed Drug for Parkinson’s Disease
17. MRPS31 loss is a key driver of mitochondrial deregulation and hepatocellular carcinoma aggressiveness
18. Pathogenic NOTCH3 Variants Are Frequent Among the Korean General Population
19. Assessment of neutralization susceptibility of Omicron subvariants XBB.1.5 and BQ.1.1 against broad-spectrum neutralizing antibodies through epitopes mapping
20. EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression
21. Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma
22. MLH1 single-nucleotide variant in circulating tumor DNA predicts overall survival of patients with hepatocellular carcinoma
23. IFI16 expression and its genotype variant are associated with NAFLD progression
24. scTyper: a comprehensive pipeline for the cell typing analysis of single-cell RNA-seq data
25. Functional Genomic Complexity Defines Intratumor Heterogeneity and Tumor Aggressiveness in Liver Cancer
26. Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer
27. Identification of genomic aberrations associated with lymph node metastasis in diffuse-type gastric cancer
28. Data from Dynamics of Genomic, Epigenomic, and Transcriptomic Aberrations during Stepwise Hepatocarcinogenesis
29. Data from Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set
30. Rational strategies for enhancing mAb binding to SARS-CoV-2 variants through CDR diversification and antibody-escape prediction
31. Supplementary Figures S1-S9 from Keratin 19 Expression in Hepatocellular Carcinoma Is Regulated by Fibroblast-Derived HGF via a MET-ERK1/2-AP1 and SP1 Axis
32. Supplementary Figures 1-4 from Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set
33. Supplementary materials from Keratin 19 Expression in Hepatocellular Carcinoma Is Regulated by Fibroblast-Derived HGF via a MET-ERK1/2-AP1 and SP1 Axis
34. Supplementary Data from Gene Expression–Based Recurrence Prediction of Hepatitis B Virus–Related Human Hepatocellular Carcinoma
35. Supplementary Tables 1-4 from Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set
36. Supplementary Figure Legends 1-4 from Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set
37. Supplementary Figure Legends 1-4 from Central Role of c-Myc during Malignant Conversion in Human Hepatocarcinogenesis
38. Data from Identification of Potential Driver Genes in Human Liver Carcinoma by Genomewide Screening
39. Supplementary Figures 1-3, Tables 1-3, Methods from Definition of Ubiquitination Modulator COP1 as a Novel Therapeutic Target in Human Hepatocellular Carcinoma
40. Data from Central Role of c-Myc during Malignant Conversion in Human Hepatocarcinogenesis
41. Supplementary Tables 1-5 from Identification of a Cholangiocarcinoma-Like Gene Expression Trait in Hepatocellular Carcinoma
42. Supplementary Methods and Materials from Identification of Potential Driver Genes in Human Liver Carcinoma by Genomewide Screening
43. Supplementary Figure 4 from Identification of Potential Driver Genes in Human Liver Carcinoma by Genomewide Screening
44. Data from Definition of Ubiquitination Modulator COP1 as a Novel Therapeutic Target in Human Hepatocellular Carcinoma
45. Supplementary Figure 2 from Identification of Potential Driver Genes in Human Liver Carcinoma by Genomewide Screening
46. Data from Identification of a Cholangiocarcinoma-Like Gene Expression Trait in Hepatocellular Carcinoma
47. Supplementary Figure Legends 1-4 from Identification of Potential Driver Genes in Human Liver Carcinoma by Genomewide Screening
48. Supplementary Tables 1-6, Figures 1-4 from Central Role of c-Myc during Malignant Conversion in Human Hepatocarcinogenesis
49. Supplementary Table 3 from Identification of Potential Driver Genes in Human Liver Carcinoma by Genomewide Screening
50. Supplementary Figure 1 from Identification of Potential Driver Genes in Human Liver Carcinoma by Genomewide Screening
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.